- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03891563
Prospective Evaluation of Sport Activity and the Development of Femoroacetabular Impingement in the Adolescent Hip (PREVIEW)
Prospective Evaluation of Sport Activity and the Development of Femoroacetabular Impingement in the Adolescent Hip (PREVIEW)
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Contact
- Name: Nicole Simunovic, MSc
- Phone Number: (289) 237-3224
- Email: simunon@mcmaster.ca
Study Contact Backup
- Name: Andrew Duong, MSc
- Phone Number: 9059232126
- Email: duonga@mcmaster.ca
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8N3Z5
- McMaster University
-
-
Quebec
-
Québec, Quebec, Canada, G1J1Z4
- Chu du Quebec
-
-
-
-
North Gyeongsang
-
Daegu, North Gyeongsang, Korea, Republic of, 41944
- Kyungpook National University Hospital
-
-
-
-
-
Rotterdam, Netherlands
- Erasmus Medical Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- asymptomatic males and females between the ages of 12-14 years
- ability to speak, understand, and read the language of the clinical site
- provision of informed child assent (if applicable) and parental consent.
Exclusion Criteria:
- hip is mature (i.e. closed physes) based on the baseline MRI scan
- hip complaints or pain in the hip
- previous trauma to the hip
- previous surgery on the hip
- significant medical co-morbidities (requiring daily assistance for ADLs)
- history of or ongoing paediatric hip disease (Legg-Calve-Perthes; slipped capital femoral epiphysis, hip dysplasia)
- participants that have contraindications and/or are unwilling to undergo an MRI (e.g. claustrophobia)
- participants who will likely have problems, in the judgment of the investigator, with maintaining follow-up
- any other reasons the investigator feels is relevant for excluding the subject.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
---|
Sport specialists, MVPA
AOSSM Criteria:
AND Activity Tracker Criteria: Greater than 180 accumulated minutes of moderate-to-vigorous physical activity (MVPA) during participation in one sport type across one week of activity tracking - Meets these criteria within either one or both years of follow-up |
Non-sport specialist, any activity level
AOSSM Criteria:
AND Activity Tracker Criteria: Greater than or less than 180 accumulated minutes of MVPA across one week of activity tracking - Meets these criteria during both years of follow-up |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of radiographic FAI
Time Frame: 2 years
|
The primary outcome is the incidence of radiographic FAI between groups at 2 years, as determined by the dedicated MRI of the hip.
We will identify both symptomatic and asymptomatic cases, where asymptomatic FAI can become symptomatic in young adulthood, and/or could be associated with idiopathic osteoarthritis later in life.
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hip function
Time Frame: 2 years
|
As determined by the Hip Outcome Score
|
2 years
|
Health-related quality of life
Time Frame: 2 years
|
As determined by the Pediatric Quality of Life questionnaire
|
2 years
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PREVIEW
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Femoroacetabular Impingement
-
Ottawa Hospital Research InstituteCompleted
-
Schulthess KlinikCompletedSymptomatic Femoroacetabular ImpingementSwitzerland
-
Ottawa Hospital Research InstituteCompletedFemoroacetabular Hip Impingement SyndromeCanada
-
Ramsay Générale de SantéRamsay santéRecruiting
-
Horsens HospitalUniversity of Aarhus; La Trobe UniversityNot yet recruitingFemoroacetabular Impingement
-
American Hip InstituteStryker OrthopaedicsRecruitingFemoroacetabular ImpingementUnited States
-
Hospital for Special Surgery, New YorkNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)RecruitingFemoroacetabular ImpingementUnited States
-
Universitaire Ziekenhuizen KU LeuvenActive, not recruitingFemoroacetabular ImpingementBelgium
-
The Hawkins FoundationTerminated
-
Peking University Third HospitalCompletedFemoroacetabular ImpingementChina